The assay is for the quantitative in vitro determination of Cystatin C in human serum or plasma. There is a growing body of evidence suggesting that Cystatin C can be used to detect kidney disease at earlier stages, which may help facilitate prevention efforts in the elderly and those with diabetes, hypertension, or cardiovascular disease.
|
|